Inclusion Criteria:
  -  Adult patients who plan to undergo simultaneous primary total knee arthroplasty on bilateral knee joint with a diagnosis of osteoarthritis or aseptic bone necrosis, but not of rheumatoid arthritis;
  -  All patients who have normal preoperative platelet count, normal prothrombin time, normal partial thromboplastin time, and normal international normalized ratio;
  -  The use of only balanced electrolyte solutions and/or albumin for plasma volume restitution.
Exclusion Criteria:
  -  Allergy to tranexamic acid;
  -  Receiving warfarin or heparin; had a history of hemophilia, deep venous thrombosis, pulmonary embolism, or renal impairment; or were pregnant;
  -  Patients with any cardiovascular problems (such as myocardiac infarction history, atrial fibrillation, angina);
  -  Patients with thromboembolic disorders, or those exhibiting a deteriorating general condition;
  -  Preoperative anemia (a hemoglobin value of <11 g/dL in females and <12 g/dL in males), refusal of blood products;
  -  Preoperative use of anticoagulant therapy within five days before surgery, fibrinolytic disorders requiring intraoperative antifibrinolytic treatment, coagulopathy (as identified by a preoperative platelet count of <150,000/mm3, an international normalized ratio of >1.4, or a prolonged partial thromboplastin time [>1.4 times normal]).